Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study - The Lancet Oncology
Por um escritor misterioso
Descrição
Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study - The Lancet Oncology
Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study - The Lancet Oncology
Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study - The Lancet
Multi-cancer early detection tests for cancer screening: a behavioural science perspective - The Lancet Oncology
Multi-cancer Early Detection Test In Symptomatic Patients, 40% OFF
The presenting symptom signatures of incident cancer: evidence from the English 2018 National Cancer Diagnosis Audit
Circulating cell-free DNA-based multi-cancer early detection: Trends in Cancer
Criteria for Evaluating Multi-cancer Early Detection Tests - touchONCOLOGY
Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study - The Lancet Oncology
Multimodal cell-free DNA whole-genome analysis combined with TET-Assisted Pyridine Borane Sequencing is sensitive and reveals specific cancer signals
Early detection of cancer
Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer
Cells, Free Full-Text
de
por adulto (o preço varia de acordo com o tamanho do grupo)
